NCT01008540 (PHRC CMV) is a NA clinical trial of depistage in Cytomegalovirus, sponsored by University Hospital, Limoges.

Who is sponsoring NCT01008540?

NCT01008540 is sponsored by University Hospital, Limoges.

What drugs are being tested in NCT01008540?

Interventions in NCT01008540: depistage.

What condition does NCT01008540 study?

NCT01008540 studies Cytomegalovirus.

Is NCT01008540 still recruiting?

NCT01008540 is currently completed. Last updated 17 July 2025.

Last reviewed 2025-07-17 · How we verify

NCT01008540: PHRC CMV

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cytomegalovirus Resistance in Transplant Patients and Bone Marrow Recipients in the Prophylaxis Era, a French Multicentric Cohort Study

Completed NA Last updated 17 July 2025

What this trial tests

NA trial testing depistage in Cytomegalovirus in 800 participants. Completed in 1 June 2012.

Timeline

1 August 2006

Primary endpoint
1 December 2010

1 June 2012

Quick facts

Lead sponsor	University Hospital, Limoges
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	800
Start date	1 August 2006
Primary completion	1 December 2010
Estimated completion	1 June 2012
Sites	33 locations across France

Drugs / interventions tested

depistage — full drug profile →

Conditions studied

Cytomegalovirus — all drugs for Cytomegalovirus →

Sponsor

University Hospital, Limoges

Who can join

Eligibility, any sex, with Cytomegalovirus. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Resistance incidence in our patients with subgroup analysis, by organ and by the use of prophylaxis or preemptive treatment

Sponsor's own description

The investigators aim is to determine the incidence of cytomegalovirus resistance to antivirals in a cohort study. The patients are included at their first CMV active infection and are followed during two years thereafter. When criteria for suspected resistance are meet, blood and urine samples are collected for virus isolation and further resistance phenotype, and for resistance genotype determination. Results are compared with baseline samples. Clinical information such as treatment, immunosuppressive regimen and clinical evolution will be collected. Through this study, the investigators aim to organize a national network for the detection and identification of CMV resistant strains that will be useful when new therapeutics will be available.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.
Hantz S, Garnier-Geoffroy F, Mazeron MC, Garrigue I, et al · · 2010 · cited 109× · PMID 20961907 · DOI 10.1093/jac/dkq368

Verify or expand the search:

Other recruiting trials for Cytomegalovirus

Currently open trials in the same condition.

NCT07358910 — Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective · recruiting
NCT06958796 — Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV) · Phase 4 · recruiting
NCT05664126 — Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Ce · Phase 2 · recruiting
NCT05575492 — A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Year · Phase 1, PHASE2 · active not recruiting
NCT03665675 — Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT · EARLY_PHASE1 · recruiting

Other University Hospital, Limoges trials

Trials by the same sponsor.

NCT07407101 — Impact of Filtration on Autologous Serum Eye Drops · NA · not yet recruiting
NCT07406425 — Evaluation of Efficacy of Coconut Oil Mouth Care for Non-autonomous Hospitalised Elderly People. · NA · not yet recruiting
NCT07436780 — B Lymphocyte Populations in the Pulmonary Microenvironment of Patients Under Mechanical Ventilation With or Without VAP · not yet recruiting
NCT07331298 — Apparent Diffusion Coefficient of the Intervertebral Disc in Children: Pilot Study · not yet recruiting
NCT07019818 — Esmolol Versus Sufentanil on the Quality of Post-cholecystectomy Recovery Laparoscopic Anaesthesia With Orotracheal Intu · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01008540 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Limoges
Last refreshed: 17 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01008540.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing